4 unknown, 1 recruiting. 5 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Unknown 4, Recruiting 1 |
| Phase 1 | 2 | Unknown 2 |
Follow Stereotactic Body Radiotherapy: new trials by email Literature Review of Stereotactic Body Radiotherapy trials Research Report on Stereotactic Body Radiotherapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Elimination of PTV Margins Based on Online Adaptive Stereotactic Radiotherapy for Early-stage Non-small Cell Lung Cancer or Pulmonary Oligometastases Online adaptive SBRT, Conventional SBRT - Adaptive Radiotherapy, Stereotactic Body Radiotherapy | Phase 2 | Recruiting | Sun Yat-sen University | 130 | 2024-05-22 | 2025-11-17 |
| Stereotactic Body Radiotherapy Combined With Cadonilimab for Advanced Refractory Malignant Solid Tumors Cadonilimab, Stereotactic body radiotherapy - Advanced Solid Tumor, Stereotactic Body Radiotherapy | Phase 1 / Phase 2 | Unknown | Peking University Third Hospital | 60 | 2023-06-21 | 2023-06-23 |
| Phase Ib/II Trial of Combining Pembrolizumab and Lenvatinib With SBRT for HCC Patients With Portal Vein Thrombosis. Lenvatinib/Pembrolizumab plus SBRT combinations - Unresectable Hepatocellular Carcinoma, Pembrolizumab | Phase 1 / Phase 2 | Unknown | National Taiwan University Hospital | 27 | 2023-03-01 | 2023-03-02 |
| Sintilimab Combined With Chemotherapy and SBRT in Limited Metastatic Head and Neck Squamous Cell Carcinoma (LM-HNSCC) Sintilimab, SBRT, Platinum based chemotherapy - Head and Neck Squamous Cell Carcinoma, Metastases | Phase 2 | Unknown | Jun-Lin Yi, MD | 50 | 2021-12-01 | 2021-11-29 |
| Local Treatment in ER-positive/HER2-negative Oligo-metastatic Breast Cancer Surgical resection, Stereotactic body radiotherapy, Radiofrequency ablation - Breast Cancer, Recurrent Breast Cancer | Phase 2 | Unknown | Gangnam Severance Hospital | 110 | 2018-08-01 | 2019-02-15 |
Breast Neoplasms (1) · Carcinoma, Non-Small-Cell Lung (1) · Diabetes Mellitus, Insulin-Dependent, 12 (1) · Neoplasm Metastasis (1) · Parkinson Disease 4, Autosomal Dominant Lewy Body (1) · Squamous Cell Carcinoma of Head and Neck (1)
Neoplasms (3) · Neoplasms by Site (3) · Breast Diseases (1) · Bronchial Neoplasms (1) · Carcinoma (1) · Carcinoma, Bronchogenic (1) · Carcinoma, Squamous Cell (1) · Head and Neck Neoplasms (1) · Lung Diseases (1) · Lung Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Glandular and Epithelial (1) · Neoplastic Processes (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Radiosurgery (2) · Drug Therapy (1) · Platinum Compounds (1) · Radiofrequency Ablation (1) · lenvatinib (1) · pembrolizumab (1) · sintilimab (1)
Gangnam Severance Hospital (1) · Jun-Lin Yi, MD (1) · National Taiwan University Hospital (1) · Peking University Third Hospital (1) · Sun Yat-sen University (1)
China (3) · South Korea (1) · Taiwan (1)
Chia-Hsien Cheng (1) · Hongqing Zhuang, M.D. (1) · Hui Liu, Professor (1) · Joon Jeong, Ph.D. (1) · Junlin Yi, MD (1)